Keyphrases
Von Willebrand Disease
100%
Von Willebrand Factor
91%
Hemostasis
62%
Laboratory Testing
49%
Thrombosis
43%
Activated Partial Thromboplastin Time (aPTT)
33%
COVID-19
28%
Lupus Anticoagulant
25%
Hemostasis Testing
24%
Direct Oral Anticoagulants
21%
Heparin
21%
Platelets
21%
Antiphospholipid Antibodies
19%
D-dimer
18%
Preanalytical Phase
18%
Prothrombin Time
18%
Venous Thromboembolism
18%
Hemostasis Laboratory
17%
Heparin-induced Thrombocytopenia
17%
Bleeding
17%
Type 2B Von Willebrand Disease
16%
Laboratory Diagnosis
16%
Fibrinogen
16%
PFA-100
15%
Laboratory Assessment
15%
Coagulation Testing
15%
Coagulation
14%
Hemophilia
14%
Thrombophilia
14%
Anticoagulants
13%
Multi-laboratory
13%
Quality Assurance Program
13%
External Quality Assurance
13%
Monoclonal Antibody
13%
Venous Thrombosis
11%
Antiphospholipid Syndrome
11%
International Normalized Ratio
11%
Australia
11%
ADAMTS13
11%
Hematology
11%
Activated Protein C Resistance
11%
Anticardiolipin Antibodies
10%
Platelet Function
10%
Collagen Binding Assay
10%
Von Willebrand Factor Antigen
10%
Vaccine-induced Immune Thrombotic Thrombocytopenia
10%
Anticoagulant Therapy
10%
Antibody Test
9%
Clot
9%
Platelet Aggregation
9%
Medicine and Dentistry
Blood Stasis
86%
Von Willebrand Disease
74%
Von Willebrand Factor
68%
Laboratory Test
48%
Thrombosis
46%
Diagnosis
42%
Diseases
32%
COVID-19
28%
Thrombocyte Function
23%
Platelet
21%
Lupus Anticoagulant
19%
Heparin
19%
Antithrombotic
18%
Prothrombin Time
17%
D-Dimer
17%
Direct Oral Anticoagulant
17%
Bleeding
17%
Venous Thromboembolism
16%
Partial Thromboplastin Time
16%
Haemophilia A
15%
Thrombophilia
15%
Antiphospholipid Antibody
15%
Blood Clotting Factor
14%
PFA-100
14%
Bleeding Disorder
14%
Laboratory Assessment
13%
Hematology
13%
Blood Clotting Factor 8
12%
Heparin-Induced Thrombocytopenia
11%
Phlebothrombosis
11%
Thrombotic Thrombocytopenic Purpura
10%
Coagulation Testing
10%
Antiphospholipid Syndrome
10%
Diagnostic Error
10%
Fibrinogen
10%
Vitamin K Antagonist
10%
Immunoassay
9%
Blood Clotting Test
9%
Von Willebrand Factor Cleaving Proteinase
9%
Clinician
9%
Monoclonal Antibody
8%
In Vitro
8%
Binding Assay
8%
Anticoagulant
8%
Pathologist
8%
Hemostat
8%
Anticoagulant Therapy
8%
Ristocetin
8%
Laboratory Diagnosis
7%
Thrombocyte Aggregation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Von Willebrand Factor
61%
Von Willebrand Disease
57%
Disease
47%
Blood Stasis
44%
Thrombosis
29%
Anticoagulant Agent
27%
Heparin
23%
Thromboplastin
22%
Coronavirinae
22%
Direct Oral Anticoagulant
17%
Prothrombin
16%
Blood Clotting Factor
15%
Blood Clotting Factor 8
15%
Bleeding
14%
Lupus Anticoagulant
13%
Haemophilia A
12%
Thrombotic Thrombocytopenic Purpura
11%
Venous Thromboembolism
11%
Bleeding Disorder
10%
Von Willebrand Factor Cleaving Proteinase
10%
Heparin Induced Thrombocytopenia
10%
D Dimer
9%
Thrombin
9%
Vein Thrombosis
9%
Rivaroxaban
9%
Ristocetin
8%
Cardiovascular Disease
7%
Desmopressin
7%
Fibrinogen
7%
Antivitamin K
7%
Syndrome
7%
Hemostatic Agent
6%
Dabigatran
6%
Warfarin
5%
Thrombophilia
5%
Apixaban
5%
SARS Coronavirus
5%
Enzyme-Linked Immunosorbent Assay
5%
Infection
5%
Antiphospholipid Antibody
5%
Polymer
5%